A2B-COVID: A method for evaluating potential SARS-CoV-2 transmission events
View ORCID ProfileChristopher J. R. Illingworth, View ORCID ProfileWilliam L. Hamilton, View ORCID ProfileChris Jackson, Ashley Popay, Luke Meredith, Charlotte J. Houldcroft, Myra Hosmillo, Aminu Jahun, Matthew Routledge, Ben Warne, Laura Caller, Sarah Caddy, Anna Yakovleva, Grant Hall, Fahad A. Khokhar, Theresa Feltwell, Malte L. Pinckert, Iliana Georgana, Yasmin Chaudhry, Martin Curran, Surendra Parmar, Dominic Sparkes, Lucy Rivett, Nick K. Jones, Sushmita Sridhar, Sally Forrest, Tom Dymond, Kayleigh Grainger, Chris Workman, Effrossyni Gkrania-Klotsas, Nicholas M. Brown, Michael P. Weekes, Stephen Baker, Sharon J. Peacock, Theodore Gouliouris, Ian Goodfellow, Daniela de Angelis, M. Estée Török
doi: https://doi.org/10.1101/2020.10.26.20219642
Christopher J. R. Illingworth
1MRC Biostatistics Unit, University of Cambridge, East Forvie Building, Forvie Site, Robinson Way, Cambridge, CB2 0SR, United Kingdom
2Institut für Biologische Physik, Universität zu Köln, Zülpicherstr. 77, 50937, Köln, Germany
William L. Hamilton
3University of Cambridge, Department of Medicine, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
4Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Chris Jackson
1MRC Biostatistics Unit, University of Cambridge, East Forvie Building, Forvie Site, Robinson Way, Cambridge, CB2 0SR, United Kingdom
Ashley Popay
5Public Health England Field Epidemiology Unit, Cambridge Institute of Public Health, Forvie Site, Cambridge Biomedical Campus, Cambridge CB2 0SR, United Kingdom
Luke Meredith
6University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Charlotte J. Houldcroft
3University of Cambridge, Department of Medicine, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Myra Hosmillo
6University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Aminu Jahun
6University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Matthew Routledge
4Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
9Public Health England Clinical Microbiology and Public Health Laboratory, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Ben Warne
3University of Cambridge, Department of Medicine, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
4Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Laura Caller
7Francis Crick Institute, 1 Midland Rd, Somers Town, London NW1 1AT, United Kingdom
Sarah Caddy
8Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW, United Kingdom
Anna Yakovleva
6University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Grant Hall
6University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Fahad A. Khokhar
6University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Theresa Feltwell
3University of Cambridge, Department of Medicine, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Malte L. Pinckert
6University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Iliana Georgana
6University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Yasmin Chaudhry
6University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Martin Curran
9Public Health England Clinical Microbiology and Public Health Laboratory, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Surendra Parmar
9Public Health England Clinical Microbiology and Public Health Laboratory, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Dominic Sparkes
4Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
9Public Health England Clinical Microbiology and Public Health Laboratory, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Lucy Rivett
4Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
9Public Health England Clinical Microbiology and Public Health Laboratory, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Nick K. Jones
4Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
9Public Health England Clinical Microbiology and Public Health Laboratory, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Sushmita Sridhar
3University of Cambridge, Department of Medicine, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
8Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW, United Kingdom
10Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, CB10 1RQ
Sally Forrest
8Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW, United Kingdom
Tom Dymond
4Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Kayleigh Grainger
4Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Chris Workman
4Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Effrossyni Gkrania-Klotsas
4Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
11MRC Epidemiology Unit, University of Cambridge, Level 3 Institute of Metabolic Science, Cambridge CB2 0SL, United Kingdom
12University of Cambridge, School of Clinical Medicine, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Nicholas M. Brown
4Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
9Public Health England Clinical Microbiology and Public Health Laboratory, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Michael P. Weekes
3University of Cambridge, Department of Medicine, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
8Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW, United Kingdom
Stephen Baker
3University of Cambridge, Department of Medicine, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
8Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW, United Kingdom
Sharon J. Peacock
3University of Cambridge, Department of Medicine, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
10Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, CB10 1RQ
Theodore Gouliouris
4Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
9Public Health England Clinical Microbiology and Public Health Laboratory, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Ian Goodfellow
6University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Daniela de Angelis
1MRC Biostatistics Unit, University of Cambridge, East Forvie Building, Forvie Site, Robinson Way, Cambridge, CB2 0SR, United Kingdom
13Public Health England, National Infection Service, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
M. Estée Török
3University of Cambridge, Department of Medicine, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
4Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, United Kingdom
Article usage
Posted October 27, 2020.
A2B-COVID: A method for evaluating potential SARS-CoV-2 transmission events
Christopher J. R. Illingworth, William L. Hamilton, Chris Jackson, Ashley Popay, Luke Meredith, Charlotte J. Houldcroft, Myra Hosmillo, Aminu Jahun, Matthew Routledge, Ben Warne, Laura Caller, Sarah Caddy, Anna Yakovleva, Grant Hall, Fahad A. Khokhar, Theresa Feltwell, Malte L. Pinckert, Iliana Georgana, Yasmin Chaudhry, Martin Curran, Surendra Parmar, Dominic Sparkes, Lucy Rivett, Nick K. Jones, Sushmita Sridhar, Sally Forrest, Tom Dymond, Kayleigh Grainger, Chris Workman, Effrossyni Gkrania-Klotsas, Nicholas M. Brown, Michael P. Weekes, Stephen Baker, Sharon J. Peacock, Theodore Gouliouris, Ian Goodfellow, Daniela de Angelis, M. Estée Török
medRxiv 2020.10.26.20219642; doi: https://doi.org/10.1101/2020.10.26.20219642
A2B-COVID: A method for evaluating potential SARS-CoV-2 transmission events
Christopher J. R. Illingworth, William L. Hamilton, Chris Jackson, Ashley Popay, Luke Meredith, Charlotte J. Houldcroft, Myra Hosmillo, Aminu Jahun, Matthew Routledge, Ben Warne, Laura Caller, Sarah Caddy, Anna Yakovleva, Grant Hall, Fahad A. Khokhar, Theresa Feltwell, Malte L. Pinckert, Iliana Georgana, Yasmin Chaudhry, Martin Curran, Surendra Parmar, Dominic Sparkes, Lucy Rivett, Nick K. Jones, Sushmita Sridhar, Sally Forrest, Tom Dymond, Kayleigh Grainger, Chris Workman, Effrossyni Gkrania-Klotsas, Nicholas M. Brown, Michael P. Weekes, Stephen Baker, Sharon J. Peacock, Theodore Gouliouris, Ian Goodfellow, Daniela de Angelis, M. Estée Török
medRxiv 2020.10.26.20219642; doi: https://doi.org/10.1101/2020.10.26.20219642
Subject Area
Subject Areas
- Addiction Medicine (216)
- Allergy and Immunology (495)
- Anesthesia (106)
- Cardiovascular Medicine (1096)
- Dermatology (141)
- Emergency Medicine (274)
- Epidemiology (9767)
- Gastroenterology (480)
- Genetic and Genomic Medicine (2308)
- Geriatric Medicine (222)
- Health Economics (462)
- Health Informatics (1559)
- Health Policy (735)
- Hematology (236)
- HIV/AIDS (503)
- Medical Education (237)
- Medical Ethics (67)
- Nephrology (257)
- Neurology (2142)
- Nursing (134)
- Nutrition (336)
- Oncology (1176)
- Ophthalmology (364)
- Orthopedics (128)
- Otolaryngology (220)
- Pain Medicine (146)
- Palliative Medicine (50)
- Pathology (311)
- Pediatrics (695)
- Primary Care Research (267)
- Public and Global Health (4657)
- Radiology and Imaging (778)
- Respiratory Medicine (623)
- Rheumatology (274)
- Sports Medicine (210)
- Surgery (251)
- Toxicology (43)
- Transplantation (120)
- Urology (94)